ICD-10-CM Billable Code

C67.0

Malignant neoplasm of trigone of bladder

Clinical Classification Guidelines

Medical Intelligence & Overview

The malignant neoplasm of the trigone of the bladder, classified under ICD-10 code C67.0, is a form of bladder cancer that originates in the trigone area of the bladder. The trigone is a triangular region located at the base of the bladder, where the ureters enter and the urethra exits. This type of cancer is significant due to its location and potential impact on urinary function and health. Early detection and understanding of this condition are crucial for effective management and treatment.

Causes & Symptoms

Clinical Causes: Smoking: Tobacco use is the most significant risk factor for bladder cancer, including trigone tumors. Chemical Exposure: Occupational exposure to aromatic amines and other carcinogenic chemicals increases risk. Chronic Bladder Inflammation: Long-term bladder infections or irritations can contribute to cancer development. Previous Radiation Therapy: Radiation directed at the pelvis may increase risk. Genetic Factors: Family history of bladder cancer can predispose individuals. Age: Incidence increases with age, particularly in people over 55. Gender: Men are more commonly affected than women.

Key Symptoms: Blood in the urine (hematuria), often unnoticed until it becomes persistent. Frequent urination or a feeling of urgency. Pain or burning sensation during urination. Pelvic pain or discomfort in the lower abdomen. Back pain, particularly if the cancer has spread.

Diagnostic & Treatment

Diagnosis Path: Urinalysis to detect blood or abnormal cells in urine. Cystoscopy: a procedure involving a thin camera inserted into the bladder to visualize the tumor and take biopsy samples. Imaging Tests: Ultrasound, CT scans, or MRI to assess the extent of the tumor and check for spread. Biopsy: tissue samples obtained during cystoscopy are examined microscopically to confirm malignancy. Urine Cytology: microscopic examination of urine cells can support diagnosis, especially in detecting high-grade tumors.

Treatment Protocols: Transurethral Resection of Bladder Tumor (TURBT): a minimally invasive procedure to remove superficial tumors. Intravesical Therapy: administering medications like Bacillus Calmette-Guérin (BCG) directly into the bladder to treat or prevent recurrence. Radical Cystectomy: surgical removal of the bladder and possibly surrounding tissues or organs, typically for invasive or high-grade tumors. Chemotherapy: systemic drugs used to target cancer cells, especially if the cancer has spread. Radiation Therapy: may be employed for local control or in patients unfit for surgery. Immunotherapy: newer treatments that stimulate the immune system to attack cancer cells.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C67.0 a billable ICD-10 code?
Yes, C67.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C67.0?
Clinical documentation must specify the nature of Malignant neoplasm of trigone of bladder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

trigone neoplasm bladder malignant